Electronic Surveys to Connect Advanced Cancer Patients to Palliative Care
This study is exploring if electronic surveys (ePROs) can help patients with advanced cancer better report their symptoms and needs, leading to earlier connection with palliative care services. Palliative care is specialized support that helps improve comfort and quality of life by addressing symptoms like pain and fatigue. The study compares two approaches: one where weekly ePROs and monthly palliative care surveys directly guide referrals, and another where weekly ePROs are used alongside standard palliative care referral practices. We are looking for about 90 participants aged 18 or older with unresectable or metastatic thoracic, gastrointestinal, or breast solid tumors who are currently receiving cancer treatment. The main goal is to see if these methods are practical and effective over 12 and 24 weeks.
- Study design
- This interventional study plans to enroll about 90 participants. It compares two different ways of using electronic surveys to connect patients to palliative care.
- What's involved
- Participants will complete weekly electronic patient-reported outcome (ePRO) symptom surveys. Some will also complete a monthly palliative care-focused survey.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure feasibility of the intervention and trial methods at 12 and 24 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Tara L. Kaufmann, MD, MSCE · PRINCIPAL_INVESTIGATOR · Dartmouth-Hitchcock Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Feasibility of the Intervention & Trial Methods12 and 24 weeks
Feasibility will be assessed as a composite of three prespecified components, each summarized as a proportion with 95% confidence intervals: Enrollment: Proportion of eligible patients who provide informed consent and are randomized. Retention: Proportion of randomized patients who complete the FACT-G at 12 weeks \[primary feasibility outcome\] and 24 weeks. Intervention Compliance: Weekly ePRO symptom surveys: Longitudinal compliance quantified as the proportion of participants who self-report at least once in each week of enrollment, averaged over the observation period. Monthly palliative-care ePRO surveys (intervention arm): Longitudinal compliance quantified as the proportion of participants who self-report at least once in each month of enrollment, averaged over the observation period.